Cellular senescence, defined as an irreversible cell cycle arrest, exacerbates the tissue microenvironment. Our previous study demonstrated that mouse uterine senescent cells were physiologically increased according to gestational days and that their abnormal accumulation was linked to the onset of preterm delivery. We hypothesized that there is a mechanism for removal of senescent cells after parturition to maintain uterine function. In the current study, we noted abundant uterine senescent cells and their gradual disappearance in wild-type postpartum mice. F4/80 + macrophages were present specifically around the area rich in senescent cells. Depletion of macrophages in the postpartum mice using anti-F4/80 antibody enlarged the area of senescent cells in the uterus. We also found excessive uterine senescent cells and decreased second pregnancy success rate in a preterm birth model using uterine p53-deleted mice. Furthermore, a decrease in F4/80 + cells and an increase in CD11b + cells with a senescence-associated inflammatory microenvironment were observed in the p53-deleted uterus, suggesting that uterine p53 deficiency affects distribution of the macrophage subpopulation, interferes with senescence clearance, and promotes senescenceinduced inflammation. These findings indicate that the macrophage is a key player in the clearance of uterine senescent cells to maintain postpartum uterine function. (Endocrinology 158: [2344][2345][2346][2347][2348][2349][2350][2351][2352][2353] 2017) C ellular senescence is a form of cell cycle arrest, with a large and vacuole-rich cytoplasm containing flattened morphology marked by increased senescenceassociated b-galactosidase (SA-b-gal) activity (1-3). Senescent cells are typically found in tumors and aging tissues. Cellular senescence halts proliferation of damaged or dysfunctional cells, which implies that it constrains progression of cancer and the aging process. As another aspect, senescent cells secrete proinflammatory cytokines and tissue-remodeling enzymes, called a senescence-associated secretory phenotype (SASP). It has been reported that SASP contributes to the disruption and remodeling of the surrounding tissue structure (3-7). Clearance of senescent cells may be important in terms of avoiding long-term retention of SASP in order to maintain healthy tissue function and preventing consequent pathologic conditions such as cancer progression and age-related dysfunction. Premalignant mouse senescent hepatocytes were removed by T cells and macrophages, and impairment of their clearance resulted in the development of hepatocellular carcinoma (8). In progeroid mice as an aging model, lifelong and late-life clearance of senescent cells by a transgenic technique and drug treatment delayed age-related pathologies, clarifying the role of senescent cell clearance in the development of age-related dysfunction (9).
Cellular senescence, defined as an irreversible cell cycle arrest, exacerbates the tissue microenvironment. Our previous study demonstrated that mouse uterine senescent cells were physiologically increased according to gestational days and that their abnormal accumulation was linked to the onset of preterm delivery. We hypothesized that there is a mechanism for removal of senescent cells after parturition to maintain uterine function. In the current study, we noted abundant uterine senescent cells and their gradual disappearance in wild-type postpartum mice. F4/80 + macrophages were present specifically around the area rich in senescent cells. Depletion of macrophages in the postpartum mice using anti-F4/80 antibody enlarged the area of senescent cells in the uterus. We also found excessive uterine senescent cells and decreased second pregnancy success rate in a preterm birth model using uterine p53-deleted mice. Furthermore, a decrease in F4/80 + cells and an increase in CD11b + cells with a senescence-associated inflammatory microenvironment were observed in the p53-deleted uterus, suggesting that uterine p53 deficiency affects distribution of the macrophage subpopulation, interferes with senescence clearance, and promotes senescenceinduced inflammation. These findings indicate that the macrophage is a key player in the clearance of uterine senescent cells to maintain postpartum uterine function. (Endocrinology 158: 2344-2353, 2017) C ellular senescence is a form of cell cycle arrest, with a large and vacuole-rich cytoplasm containing flattened morphology marked by increased senescenceassociated b-galactosidase (SA-b-gal) activity (1) (2) (3) . Senescent cells are typically found in tumors and aging tissues. Cellular senescence halts proliferation of damaged or dysfunctional cells, which implies that it constrains progression of cancer and the aging process. As another aspect, senescent cells secrete proinflammatory cytokines and tissue-remodeling enzymes, called a senescence-associated secretory phenotype (SASP). It has been reported that SASP contributes to the disruption and remodeling of the surrounding tissue structure (3) (4) (5) (6) (7) . Clearance of senescent cells may be important in terms of avoiding long-term retention of SASP in order to maintain healthy tissue function and preventing consequent pathologic conditions such as cancer progression and age-related dysfunction. Premalignant mouse senescent hepatocytes were removed by T cells and macrophages, and impairment of their clearance resulted in the development of hepatocellular carcinoma (8) . In progeroid mice as an aging model, lifelong and late-life clearance of senescent cells by a transgenic technique and drug treatment delayed age-related pathologies, clarifying the role of senescent cell clearance in the development of age-related dysfunction (9) . Senescent cells are found not only in pathologic conditions, such as tumors and aging tissues, but also in the physiological developmental process (10) (11) (12) , suggesting that senescent cell clearance plays an important role in maintaining homeostasis in physiological conditions. Indeed, macrophages removed senescent cells in the mammalian embryonic development process and salamander limb regeneration (10) (11) (12) .
We previously reported that senescent cells were present during the course of a normal pregnancy in the mouse decidua, the stromal region of the implantation site, and that decidual SA-b-gal staining became more intense as parturition approached (13) . In addition, the exacerbation of decidual senescence observed in mice with uterine-specific p53 deletion led to preterm birth (13) (14) (15) (16) . Interestingly, we found that human deciduae from women with preterm birth, which were abundant with senescent cells, had more senescent cells than term decidua with less intense SA-b-gal staining (14) , suggesting the significance of decidual senescence in determining the timing of parturition. These findings indicate the possible physiological and pathologic role of senescent cells in parturition. However, the details of uterine senescent cells after parturition remain unclear. It is not known whether all the senescent cells are shed during parturition or if there are some remnants of senescent cells in the postpartum uterus. If the senescent cells are present in the postpartum uterus, we need to clarify the effects of these cells on uterine functions, including subsequent pregnancy outcome.
To investigate the presence of senescent cells in the postpartum uterus and to further clarify the influence of the senescent cells on uterine function, we examined postpartum uteri of both wild-type (WT) and uterine p53-deleted mice. Notably, senescent cells were observed in the area of the implantation scar in WT postpartum mice, and these cells gradually disappeared within a month. F4/80 + macrophages were physiologically involved in the clearance of uterine senescent cells in WT postpartum mice. In addition, the persistent presence of senescent cells and the skewed macrophage subpopulation in p53-deleted postpartum uteri were linked to failure in secondary pregnancy. Our new findings revealed that the macrophage is a key player in the clearance of senescent cells to maintain function in the mouse postpartum uterus.
Materials and Methods

Mice
Mice with uterine deletion of p53 (Trp53 f/f and p53 d/d mice were generated as previously described (16) . ICR WT, p53 f/f , and p53 d/d females (6 to 12 weeks old) were mated with fertile ICR WT males, and day 1 of pregnancy (D1) was defined as the morning when a vaginal plug was observed. All pregnant mice were housed individually. Pregnant females were observed from D17 every morning (0900 to 1100 hours), and postpartum day 1 (PPD1) was defined as the morning when pregnant females had newborn pups. Mice used in this study were housed in the University of Tokyo Animal Care Facility according to the institutional guidelines for the use of laboratory animals. The experimental procedures were approved by the institutional animal research committee.
Macrophage depletion
Macrophages were depleted according to the protocol of previous studies (19) (20) (21) . Briefly, hybridoma cells producing anti-F4/80 antibody (HB-198 hybridoma; ATCC, Manassas, VA) were cultured in antibiotic-free RPMI-1640 containing 5% fetal bovine serum, and anti-F4/80 antibody was purified from the culture media using MabTrap Kit (GE Healthcare, Tokyo, Japan). Antibody concentration was measured using a protein assay reagent (Bio-Rad, Hercules, CA). To perform macrophage depletion in the mouse postpartum uterus, intraperitoneal injection of anti-F4/80 antibody was performed from PPD1 to PPD7 (250 mg/d per mouse).
Preterm birth mouse model
The preterm birth mouse model was established as previously described (14) . In short, p53 d/d and p53 f/f pregnant mice were injected with lipopolysaccharide (LPS) intraperitoneally (10 mg per mouse; InvivoGen, San Diego, CA) on D16 (0900 to 1100 hours). Mice were observed every morning (D17 to D20, 0900 to 1100 hours) and in the evening of D18 (1800 to 2000 hours). Preterm birth was defined as birth occurring earlier than D18 evening.
Analysis of secondary pregnancy
A preterm birth mouse model using LPS-treated uterine p53-deleted mice was used. p53 d/d and p53 f/f postpartum mice were mated with WT fertile males from PPD1 evening to PPD2 morning, and a vaginal plug was checked on PPD2 morning (22) . After confirmation of the vaginal plug, living pups were euthanized. Mated postpartum mice were observed daily (0900 to 1100 hours) for 4 weeks and were checked to determine whether parturition occurred in their second pregnancy. To deplete F4/80 + macrophages from LPS-treated p53 f/f mice, anti-F4/80 antibody was injected intraperitoneally from PPD1 to PPD7 every other day.
SA-b-gal staining
Staining of SA-b-gal activity was performed as previously described (16, 23) . In short, frozen sections (16 mm) were fixed in 0.5% glutaraldehyde in phosphate-buffered saline and were stained for 6 hours in phosphate-buffered saline (pH, 5.5) containing 1 mM magnesium chloride, 1 mg/mL X-gal, and 5 mM each of potassium ferricyanide and potassium ferrocyanide. Sections were counterstained with eosin. To investigate the effect of macrophage depletion on SA-b-gal activity in the mouse postpartum uterus, daily intraperitoneal injection of anti-F4/80 antibody was performed from PPD1 to PPD7.
Immunohistochemistry
Immunostaining was performed using 10% formalin-fixed paraffin-embedded sections using specific antibodies to asmooth muscle actin (Agilent, Santa Clara, CA), CD3 (Agilent), cytokeratin (TROMA-1; Developmental Studies Hybridoma Bank, Iowa City, IA), F4/80 (Bio-Rad), neutrophil marker NIMP-R14 (Santa Cruz Biotechnology, Dallas, TX), p21 (Abcam, Cambridge, UK), CD11b (Abcam), and mannose receptor (Abcam). Acetone-fixed frozen sectioning was performed for immunostaining using specific antibodies to CD11b (Developmental Studies Hybridoma Bank) and perforin (Torrey Pines Biolabs, Secaucus, NJ). For immunoenzyme detection, ImmPACT NovaRED (Vector Laboratories, Cambridgeshire, UK) was used for coloring, and sections were counterstained with hematoxylin. For immunofluorescence detection, Alexa Fluor 488-conjugated anti-rat immunoglobulin G and Alexa Fluor 555-conjugated anti-rabbit immunoglobulin G were used for protein detection, and nuclear staining was performed with 4 0 ,6-diamidino-2-phenylindole. Antibody information is summarized in Table 1 .
Quantitative polymerase chain reaction
Uterine RNA was extracted using Isogen (Nippon Gene, Toyama, Japan). Postpartum uteri were cut between each implantation scar, and uterine RNA was extracted from at least two fragments individually. For reverse transcription, ReverTra Ace qPCR RT Master Mix with gDNA Remover (TOYOBO, Osaka, Japan) was used. Quantitative polymerase chain reaction (PCR) was performed as previously described (35) . A housekeeping gene Actb was used as an internal control, and SYBR Premix Ex Taq II (TaKaRa, Shiga, Japan) was used. Primers used in this study are shown in Table 2 .
Statistical analysis
Statistical analyses were performed using a two-tailed Student t test or x 2 test. P , 0.05 was considered statistically significant (Table 3) . 
Results
Senescent cells were present in the implantation scar of the postpartum uterus and gradually disappeared within a month We previously reported that abundant senescent cells are present at the decidua, the stromal region of implantation site (16) . Because decidual tissues are basically shed at parturition, stromal senescent cells are supposed to be removed from the uterus at the time of delivery. However, we speculated that a part of these cells remain in the postpartum uterus; we conducted SA-b-gal staining in mouse postpartum uteri because SA-b-gal, an established marker of cellular senescence (2), detects promotion of the lysosomal activity of senescent cells (36) . Abundant cells with heightened SA-b-gal activity were observed in the area of the implantation scar, where the placenta was attached. These senescent cells gradually decreased and then almost completely disappeared after a month [ Fig. 1 and Supplemental Fig. 1(a) ]. The expression pattern of cyclin-dependent kinase inhibitor p21, which regulates cellular senescence and is used as a surrogate marker of cellular senescence (13) , was similar to that of SAb-gal staining in the implantation scar (Supplemental Fig. 2 ). These findings indicate that elimination of uterine senescent cells may be associated with uterine remodeling in the postpartum period. In addition, very few cytokeratin + and a smooth muscle actin + cells were observed in the senescence area (Supplemental Fig. 3 ). Taken together, senescent cells were present in the stromal region of the mouse postpartum uterus, suggesting that stromal senescent cells during pregnancy are retained in the postpartum uterus. speculated that clearance of these cells is a crucial process for postpartum uterine remodeling and recovery. Previous studies pointed out that leukocytes participate in the clearance of senescent cells (8, 23, 37) ; therefore, we examined the localization of various leukocyte subsets in the postpartum uterus. Cells with F4/80, a well-known marker of macrophages, were present specifically in the implantation scar, where there were many senescent cells, whereas CD11b + cells were little on both PPD4 and PPD8 (Fig. 2) .
We also found a population of F4/80/CD11b doublepositive cells among CD11b + cells (Supplemental Fig. 4 ). In the senescence area, natural killer (NK) cells (perforin), T cells (CD3), and neutrophils (NIMP-R14) were scarcely observed (Supplemental Fig. 5 ). These results suggest that F4/80 + macrophages may be involved in the clearance of postpartum uterine senescent cells. To examine this possibility, we next depleted F4/80 + macrophages from WT postpartum mice by daily injection of anti-F4/80
antibody from PPD1 to PPD7 (250 mg/d per mouse) and observed the localization of senescent cells on PPD8. Uterine macrophages could be successfully eliminated by injection of anti-F4/80 antibody (Supplemental Fig. 6 ). Abnormal accumulation of senescent cells was observed in the macrophage-depleted uterus on PPD8 [ Fig. 3 and Supplemental Fig. 1(b) ]. These findings suggest that clearance of senescent cells is dependent on F4/80 + macrophages, probably as part of postpartum uterine remodeling.
Postpartum cellular senescence was exacerbated and the subsequent pregnancy outcome was disturbed in mice with uterine p53 deletion Mice with uterine p53 deletion (Trp53 loxP/loxP Pgr Cre/+ ,
) have been used as a model of spontaneous preterm birth with exacerbated decidual cellular senescence (13, 16) , and LPS treatment at pregnancy D16 provoked preterm birth in all p53 d/d female mice (14) . Our previous study showed that LPS injection itself did not cause cellular senescence (13) . In this study, we examined residual cellular senescence in the postpartum uterus of LPS-treated p53 (Figs. 1 and 2) , whereas CD11b + cells were scarcely observed (Fig. 2) . We Macrophages can be classified into two subsets using specific gene expression profiles and their distinct functions: classically activated macrophages (M1 cells) that secrete proinflammatory cytokines controlling the host defense mechanism and alternatively activated macrophages (M2) that have higher phagocytotic activity promoting tissue remodeling (38) . It has been reported that mannose receptor is highly expressed in M2 macrophages (39, 40) , so we performed double staining of the mannose receptor and CD11b using the PPD8 uterus. We saw abundant mannose senescence-associated inflammatory microenvironment, and a poor secondary pregnancy outcome. Taken together, these findings revealed a physiological system of senescent cell clearance by macrophages in the postpartum uterus, which may be involved in successful postpartum uterine recovery to prepare for a secondary pregnancy.
In previous reports, various leukocytes such as NK cells and CD4 + T cells were implicated in senescence clearance (8, 23) . As for the uterus, it was reported that NK cells were scarcely present in the peripartum uterus (41), and we did not detect the accumulation of lymphocytes or neutrophils in the postpartum senescence area. Our data clearly showed senescence clearance by F4/80 + macrophages, which is similar to findings in mouse models of liver cancer and fibrosis (8, 37) . These findings suggest that the macrophage is a key player in the uterine system of senescence clearance. Because F4/80 antibody treatment significantly diminished senescence clearance, we hypothesized that the F4/80 + subpopulation of macrophages was involved in the clearance of uterine senescent cells. A hallmark feature of senescent cells is SASP (3-5, 7). SASP factors, which include not only inflammatory cytokines but also various chemokines, recruit immune cells to remove senescent cells (42) . The current study showed that the p53 Removal of senescent cells is critical in both cancer and aging-related disorders such as fibrosis. When this mechanism does not work, senescent cells continue to secrete SASP factors, including inflammatory cytokines, and the retention of the inflammatory status disrupts the tissue remodeling process, which leads to tissue dysfunction (3-7). In hepatocellular carcinoma, tumor clearance is triggered by p53-induced cellular senescence in association with senescence-induced innate immunity change (42) . In other pathologic conditions, such as liver fibrosis and atherosclerosis, disturbance of the senescence clearance mechanism results in the exacerbation of diseases owing to failure of tissue remodeling (9, 37) . However, in physiological conditions, the importance of senescence clearance has so far been noted only in the developmental process (10) (11) (12) . During development, regulated tissue remodeling following cellular senescence contributes to embryonic growth and patterning (11, 12) . Parturition is a process of physiological uterine remodeling to prepare for subsequent pregnancy (32) . Our finding of postpartum uterine senescence clearance elucidates the role of physiological senescence clearance in terms of maintenance of tissue homeostasis.
Until recently, a causal relationship between uterine inflammation and pregnancy was not clear; however, recent clinical data indicate that chronic endometrial inflammation is related to implantation failure (43) (44) (45) (46) (47) (48) . This causal relationship between chronic uterine inflammation and pregnancy success is compatible with our findings that p53 d/d postpartum mice with a heightened inflammatory microenvironment had subsequent pregnancy failure.
In conclusion, the current study demonstrated the presence of postpartum uterine senescence clearance by macrophages as a process of physiological uterine remodeling and its possible significance in subsequent pregnancy success.
